Brief: Blackrock Inc's Long Position In H-Shares Of Sinopharm Group Reduced To 6.94% On Jan 10 - HKEX
Jan 15 (Reuters) - HKEX:
* BLACKROCK INC'S LONG POSITION IN H-SHARES OF SINOPHARM
GROUP
REDUCED TO 6.94% ON JAN 10 FROM 7.03% - HKEX
Source text
Further company coverage: 1099.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sinopharm
See all newsBrief: Sinopharm Group Says 9M Sinopharm Accord Net Income Attributable RMB952.5 Million (Oct 20)
Medical products distributor Sinopharm Group's prelim 9-month revenue slips
Brief: BlackRock's Long Position In H Shares Of Sinopharm Reduces To 9.23% On Oct 13, HKEX Shows
Sinopharm interim revenue edges down on softness in pharmaceutical distribution business
Brief: Sinopharm Group To Sell 30.13% Stake In China National Medicines Guorui Pharmaceutical For